Forum Discussion

Marianne_BCNA's avatar
8 years ago

New Australian MonaLisa TouchTM clinical trial

MonaLisa TouchTM (MLT) is a new, non-hormonal treatment for women with vaginal atrophy (VA).

Vaginal atrophy most commonly occurs after menopause, when oestrogen levels fall and the walls of the vagina become thinner, drier and may become inflamed. VA also affectS women who have had breast cancer, where medications affect oestrogen levels and bring on menopausal symptoms. This often distressing condition can cause painful burning, itching, dryness, painful intercourse and pain during urination.

MLT is a type of fractional CO2 laser technology treatment which involves pin-point laser applications to the vaginal lining. At present, there is not enough evidence about the effectiveness of MonaLisa TouchTM for it to be recommended as a medical treatment. It is currently expensive to access and there is no Medicare rebate available. This article provides an interesting overview of fractional CO2 therapy for vaginal atrophy.

University of NSW Associate Professor Jason Abbott (a gynaecologist and obstetrician) is currently running a clinical trial in Australia which will evaluate how effective MonaLisa TouchTM is in treating postmenopausal VA symptoms in women with a history of breast cancer.

The study is being conducted in Sydney.

You can read more about the trial on our Clinical trials for women who have completed active treatment webpage. 

  • Thanks for this Marianne, I'm definitely going to see if I can be involved as this is an issue that plagues me. Jane xx
  • It improved things Paula, @mum2jj, but not back to completely normal. I was fine after chemo and for 2 years on Tamoxifen but having ovaries out at 49 and then 6 months on Femara seemed to be the problem for me. It was very sudden.
    Deanne xxx
  • @Deanne, how well did it work for you? @Afraser I don’t know if Fe area is solely to blame. I am triple neg and can’t take any of those drugs but did do chemo twice in 18mths and have vaginal atrophy. I think the chemopause has a lot to do with it too. 
    Hugs ladies. 
    Paula x
  • Interesting. Like @zoffiel I am wary about lasering my vagina, but would also like to see some more research done. I too have little doubt that Femara has been instrumental in the problem, which like @Deanne manifested itself within 6 months of starting hormonal treatment. 
  • Yes, I agree @MKitty68. I had to drive to Kedron for treatment from the Sunshine Coast as otherwise there was a waiting list for nearly 6 months locally. It cost $1800 for 3 treatments and gynaecologist reduced her fee to $450 for a further 2 treatments. I am on Femara which caused atrophy within the first 6 months. 
  • I would also be very interested in being a part of this, however I am in Brisbane, a shame someone here couldn't do the same. 
    In Brisbane these treatments are in the vicinity of $2,000 for the three treatments
  • Shame I live so far away, otherwise would be very interested.
  • Thanks Marianne. I'd register for that but, of course, being out in the sticks in another state I can't. 

    It takes a certain degree of confidence, or desperation, to agree to have ones vagina lasered, but it would be excellent if they had a big enough sample to establish if this treatment works. VA is one of the less recognised side effects of cancer treatment. I'd go to considerable trouble and expense to restore some semblance of my previous sex life if I thought the treatment would work.